Cargando…
Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen
IRX-2 is an injectable cancer immunotherapy composed of cytokines purified from stimulated normal-donor peripheral blood mononuclear cells. In a phase 2a trial (n = 27), neoadjuvant IRX-2 significantly increased lymphocyte infiltration (LI) into resected head and neck tumors and was associated with...
Autores principales: | Berinstein, Neil L., McNamara, Michael, Nguyen, Ariane, Egan, James, Wolf, Gregory T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927542/ https://www.ncbi.nlm.nih.gov/pubmed/29721379 http://dx.doi.org/10.1080/2162402X.2017.1423173 |
Ejemplares similares
-
IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers
por: Wolf, Gregory T, et al.
Publicado: (2018) -
Peptide Based Vaccine Approaches for Cancer—A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory Regimen
por: Naylor, Paul H., et al.
Publicado: (2011) -
Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells
por: Da Silva, Diane M., et al.
Publicado: (2016) -
Site-Directed Mutagenesis of IRX9, IRX9L and IRX14 Proteins Involved in Xylan Biosynthesis: Glycosyltransferase Activity Is Not Required for IRX9 Function in Arabidopsis
por: Ren, Yanfang, et al.
Publicado: (2014) -
Irx3 and Irx5 - Novel Regulatory Factors of Postnatal Hypothalamic Neurogenesis
por: Dou, Zhengchao, et al.
Publicado: (2021)